Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IBIO iBio Inc

0.03 (2.48%)
Last Updated: 15:40:00
Delayed by 15 minutes


Draw Mode:

Volume 73,053
Bid Price
Ask Price
News -
Day High 1.26


52 Week Range


Day Low 1.18
Company Name Stock Ticker Symbol Market Type
iBio Inc IBIO AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03 2.48% 1.24 15:40:00
Open Price Low Price High Price Close Price Prev Close
1.22 1.18 1.26 1.21
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
359 73,053 $ 1.23 $ 89,952 - 1.0214 - 52.00
Last Trade Time Type Quantity Stock Price Currency
15:40:38 50 $ 1.2311 USD

iBio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.22M 3.48M - 0 -65.01M -18.66 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

iBio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No IBIO Message Board. Create One! See More Posts on IBIO Message Board See More Message Board Posts

Historical IBIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.241.261.15011.19328,8880.000.00%
1 Month1.121.301.07671.19122,0370.1210.71%
3 Months1.561.581.02141.26138,655-0.32-20.51%
6 Months6.408.5681.02144.67340,522-5.16-80.63%
1 Year24.2052.001.021418.19550,662-22.96-94.88%
3 Years36.6073.201.021421.392,664,133-35.36-96.61%
5 Years17.872157.001.0037.186,642,899-16.63-93.06%

iBio Description

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc.

Your Recent History

Delayed Upgrade Clock